Sennoside A

Sennoside A has been studied in 2 papers since 2025: none in people yet, 2 in animals; 1 in the past year. The research so far is in animals. The newest paper, Jul 14, 2026: “Anti-Malignancy and Anti-Inflammation Properties of Emodin, an Essential Constituent in Popular Laxative Botanicals”.

Intervention

2 papers study it1 findingUpdated

PubChemChEBI

See all 2 papers on sennoside A

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: National Natural Science Foundation of China and 1 more
  • Animals2

What did studies of sennoside A find?

1

Studies of sennoside A measured one outcome, retinal degeneration.

Retinal degeneration

downin mice1

1 study
  1. Sennoside A decreases retinal degeneration in mice (light-induced).

    “identified sennoside A as a candidate ALDH2 activator, which alleviated light-induced retinal degeneration in mice.”

    Animalslight-induced

    Detecting ALDH2 activity in live cells via conditional metabolic labeling

    Chemical science

More on Retinal degeneration

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months